Minted: - / 5000

4619 Emicerfont
b3432a75a3c1cf4f897f5f02e99316298865df90e7ec4b882d580acba8358b26

Properties

Background

Brown
Bottle

Light blue
Cap

Light green
Syringe

Red
Bubbles
No
Drops
No
Label
Pill

Chemistry

Formula
C22H24N6O2
Carbon
22
Polarity
Neutral

Emicerfont (GW-876,008) is a drug developed by GlaxoSmithKline which acts as a CRF-1 antagonist. Corticotropin releasing factor (CRF), also known as Corticotropin releasing hormone, is an endogenous peptide hormone which is released in response to various triggers such as chronic stress, and activates the two corticotropin-releasing hormone receptors: CRF₁ and CRF₂. This then triggers the release of corticotropin (ACTH), another hormone which is involved in the physiological response to stress.

From Wikipedia, the free encyclopedia. License: CC BY-SA.